AA
VIVO

ALPS Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

ALPS Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-13,901
Closed -$308K – 1048
2021
Q2 		$308K Hold
13,901
– – ﹤0.01% 818
2021
Q1 		$365K Sell
13,901
-3,445
-20% -$81.9K ﹤0.01% 538
2020
Q4 		$324K Sell
17,346
-353
-2% -$6.59K ﹤0.01% 658
2020
Q3 		$301K Buy
+17,699
New +$344K ﹤0.01% 517
2015
Q3 		– Sell
-26,806
Closed -$500K – 790
2015
Q2 		$500K Buy
26,806
+416
+2% +$7.71K ﹤0.01% 512
2015
Q1 		$504K Buy
+26,390
New +$488K ﹤0.01% 569
2014
Q1 		– Sell
-20,544
Closed -$468K – 690
2013
Q4 		$468K Buy
20,544
+9,966
+94% +$245K ﹤0.01% 456
2013
Q3 		$250K Buy
+10,578
New +$247K ﹤0.01% 437

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

ALPS Advisors's VIVO Position: Q3 2021 in Review

ALPS Advisors sold out of Meridian Bioscience Inc (VIVO) in Q3 2021, closing a stake of 13,901 shares — an estimated $308K sold.

ALPS Advisors first reported a position in VIVO in Q3 2013 and held it in 8 quarters. The position peaked at $504K in Q1 2015. 180 funds tracked by Wall St. Rank hold VIVO as of Q3 2021.

  • ALPS Advisors reported no remaining Meridian Bioscience Inc position as of Q3 2021 after selling out during the quarter.
  • ALPS Advisors sold 13,901 Meridian Bioscience Inc shares in Q3 2021, an estimated $308K.
  • ALPS Advisors first reported a position in Meridian Bioscience Inc in Q3 2013 and held it in 8 quarters.
  • ALPS Advisors's Meridian Bioscience Inc position peaked at $504K in Q1 2015.
  • 180 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2021.

Based on ALPS Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.